Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > We use to have great discussions here

<< Previous

Bullboard Posts

Next >>

Comment by Joeking123on Aug 02, 2021 4:39pm

54 Views

Post# 33640407

RE:We use to have great discussions here

TheWeakendz wrote: But TheWeakendz over. JoeKing123, the board is all yours. Man, my biov and tsf are down big. Small bets without any headaches. GLTA.

take your biov to the biov board and have at er

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management